Home Research Departments / Research Groups / Institutes Child and Adolescent Psychiatry and Psychotherapy Research Groups RG Clinical Neuroscience of Mood Disorders

RG Clinical Neuroscience of Mood Disorders

Head

M.D., Ph.D., FRCPsych

Dr. med. Argyris Stringaris

e-mail

Building 15K, Room 206, MSC 2670
BETHESDA, MD 20814
Phone: +1 301 443 8019
Fax: +1 301 594 9959

The National Institute of Mental Health Information Resource Center

 

Medical Director of the Clinic of Child and Adolescent Psychiatry and Psychotherapy and Deputy Director of the Central Institute of Mental Health (CIMH)

Prof. Dr. Dr. Tobias Banaschewski

Phone: +49 621 1703-4501

Fax: +49 621 1703-4505

e-mail

Secretariat:
Sylke Rauscher, Phone: +49 (0)621 1703-4502, e-mail 
Selina Grigat, Phone: +49 (0)621 1703-4503, e-mail

Main Medical Building, 3rd Floor, Room 340

 

Personal consultant / Research Aide Adviser:
Dr. med. Nina Christmann, Phone.: +49 (0)621 1703- 6960, e-mail

Main Medical Building, 3rd Floor, Room 380

 

 

Description

The research group “Clinical Neuroscience of Mood Disorders” focuses on the aim of gaining a better understanding of the genesis, function and clinical relevance of mood and emotional dysregulation in childhood and adolescence.

Although affective disorders are among the most severe and prevalent disorders worldwide, the genesis and function of mood and its changes are still largely unexplained. Emotional dysregulation is a transdiagnostic concept that is highly relevant to many disorders in childhood and adolescence. Mood changes and emotional dysregulation play an essential role not only in the context of affective disorders in childhood and adolescence, but also, for example, in hyperkinetic disorders, schizophrenic disorders or personality disorders. For those affected, other associated disorders also represent an additional burden.

In addition to the question of the genesis and definition of mood, our research group also focuses on the investigation of mood characteristics and emotional dysregulation as well as on the optimisation of existing and the development of new therapy concepts. To this aim, we use state-of-the-art methods such as neuroimaging (e.g. fMRI, MEG), computational methods as well as epidemiological and clinical trials.



Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de